Group structure
6 companies in 4 countries
Loading…
6 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AKINETON | Biperiden | Brazil | Authorised | 2017 |
| ANDROCUR | Cyproterone | Brazil | Authorised | 2024 |
| GLAMETIX | Glatiramer acetate | Brazil | Authorised | 2022 |
| KEFLEX | Cefalexin | Brazil | Authorised | 2009 |
| NOOTROPIL | Piracetam | Brazil | Authorised | 2026 |
| RESOLOR | Prucalopride | Brazil | Authorised | 2023 |
| SABIVARNEX | Flurbiprofen | Brazil | Authorised | 2026 |
| TARGUS | Flurbiprofen | Brazil | Authorised | 2012 |
| TIORFAN | Acetorphan | Brazil | Authorised | 2005 |
| TRANQUINAL | Alprazolam | Brazil | Authorised | 2011 |
| Tranquinal SLG | Alprazolam | Brazil | Authorised | 2009 |
| TRIFAMOX | Amoxicillin, Sulbactam pivoxila, Sulbactam | Brazil | Authorised | 2010 |
| ABELCET | Anfotericina b | Brazil | Cancelled | 2009 |
| AKINETON® TABLETAS2 mg · Tableta | Biperiden | Colombia | unknown | 1999 |
| BAGOHEPAT RAPIDA ACCION100 mg - 100 mg · Cápsula blanda | Extracto seco cynara scolymus acido dehidrocolico | Argentina | unknown | |
| BONVIVA | Ibandronic acid | Brazil | Cancelled | 2018 |
| BUFEDIL | Buflomedil | Brazil | Cancelled | 2011 |
| COSMEGEN | Dactinomycin | Brazil | Cancelled | 2008 |
| DIOXAFLEX | Diclofenac | Brazil | Cancelled | 2007 |
| DISLEP | Levosulpirida | Brazil | Cancelled | 2009 |
| ELSPAR | Asparaginase | Brazil | Cancelled | 2008 |
| EUGERIAL | Nimodipine | Brazil | Cancelled | 2006 |
| GLIOTEN | Enalapril | Brazil | Cancelled | 2012 |
| GLIOTEN | Enalapril | Brazil | Cancelled | 2006 |
| GLIOTENZIDE | Enalapril, Hydrochlorothiazide | Brazil | Cancelled | 2006 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 36 | 12 | 24 | CompaniesAll medicines |
| Argentina | 1 | 0 | 1 | CompaniesAll medicines |
| Colombia | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Singapore
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Licence: Creative Commons Attribution
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM renovacion; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Report an error or request removalCorrections from the company itself are welcome.
Keep BAGÓ’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.